{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:17:34Z","timestamp":1744431454483,"version":"3.40.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["semthorcardiovascsurg.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1053\/j.semtcvs.2024.11.009","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T08:03:20Z","timestamp":1733904200000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["New Directions in Coronary Revascularization for Refractory Angina: Gene Therapy and the Lizard Heart"],"prefix":"10.1053","volume":"37","author":[{"given":"Ahmed H.","family":"Aly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahush A.","family":"Mokadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.semtcvs.2024.11.009_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Neumann","year":"2020","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1053\/j.semtcvs.2024.11.009_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrcardio.2013.200","article-title":"Treatment of refractory angina in patients not suitable for revascularization","volume":"11","author":"Henry","year":"2013","journal-title":"Nat. Rev Cardiol"},{"issue":"34","key":"10.1053\/j.semtcvs.2024.11.009_bib3","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/eurheartj\/eht165","article-title":"Long-term survival in patients with refractory angina","volume":"34","author":"Henry","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1053\/j.semtcvs.2024.11.009_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2019.08.055","article-title":"Refractory angina: from pathophysiology to new therapeutic nonpharmacological technologies","volume":"13","author":"Gallone","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1053\/j.semtcvs.2024.11.009_bib5","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2005.06.079","article-title":"A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease","volume":"46","author":"Leon","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1053\/j.semtcvs.2024.11.009_bib6","first-page":"1","article-title":"Transmyocardial laser revascularization versus medical therapy for refractory angina","volume":"2015","author":"Briones","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"10.1053\/j.semtcvs.2024.11.009_bib7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199909303411402","article-title":"Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease","volume":"341","author":"Frazier","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.semtcvs.2024.11.009_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.carrev.2014.10.011","article-title":"The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina","volume":"16","author":"Alunni","year":"2015","journal-title":"Cardiovasc Revascularization Med"},{"issue":"8","key":"10.1053\/j.semtcvs.2024.11.009_bib9","article-title":"EXACT trial: results of the phase 1 dose-escalation study","volume":"16","author":"Povsic","year":"2023","journal-title":"Circ Cardiovasc Inter"},{"issue":"3","key":"10.1053\/j.semtcvs.2024.11.009_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.carrev.2018.05.018","article-title":"Intramyocardial autologous CD34+ cell therapy for refractory angina: a meta-analysis of randomized controlled trials","volume":"20","author":"Velagapudi","year":"2019","journal-title":"Cardiovasc Revascularization Med"},{"issue":"12","key":"10.1053\/j.semtcvs.2024.11.009_bib11","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/CIRCRESAHA.118.314118","article-title":"The impact of cell therapy on cardiovascular outcomes in patients with refractory angina: an updated systematic review and meta-analysis of randomized controlled trials","volume":"124","author":"Jones","year":"2019","journal-title":"Circ Res"},{"issue":"7","key":"10.1053\/j.semtcvs.2024.11.009_bib12","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1053\/j.semtcvs.2024.11.009_bib13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0735-1097(03)00329-2","article-title":"Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease","volume":"41","author":"Bonetti","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1053\/j.semtcvs.2024.11.009_bib14","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jcin.2017.06.062","article-title":"First experience with the coronary sinus reducer system for the management of refractory angina in patients without obstructive coronary artery disease","volume":"10","author":"Giannini","year":"2017","journal-title":"JACC Cardiovasc Inter"},{"issue":"2","key":"10.1053\/j.semtcvs.2024.11.009_bib15","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jcin.2018.09.032","article-title":"Coronary sinus reducer implantation to reduce the ischemic burden in refractory angina","volume":"12","author":"Gallone","year":"2019","journal-title":"JACC Cardiovasc Inter"},{"issue":"6","key":"10.1053\/j.semtcvs.2024.11.009_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semtcvs.2024.11.009_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijcard.2016.10.105","article-title":"Efficacy of spinal cord stimulation as an adjunct therapy for chronic refractory angina pectoris","volume":"227","author":"Imran","year":"2017","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1053\/j.semtcvs.2024.11.009_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.100.2.135","article-title":"Cardiac sympathetic denervation after transmyocardial laser revascularization","volume":"100","author":"Al-Sheikh","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.semtcvs.2024.11.009_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/2049463714549775","article-title":"Temporary sympathectomy in chronic refractory angina: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Denby","year":"2015","journal-title":"Br J Pain"},{"issue":"9","key":"10.1053\/j.semtcvs.2024.11.009_bib20","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1161\/CIR.0000000000001168","article-title":"AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.semtcvs.2024.11.009_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0003-4975(99)00842-5","article-title":"Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization","volume":"68","author":"Horvath","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2024.11.009_bib22","unstructured":"Chan J, Horvath K. Transmyocardial Revascularization Society of Thoracic Surgery E-Book. Last updated August 5, 2023."},{"issue":"5","key":"10.1053\/j.semtcvs.2024.11.009_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41434-021-00295-1","article-title":"Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-D\u0394N\u0394C gene therapy eight-year follow-up of phase I KAT301 study","volume":"29","author":"Leikas","year":"2021","journal-title":"Gene Ther"},{"issue":"8","key":"10.1053\/j.semtcvs.2024.11.009_bib24","doi-asserted-by":"crossref","first-page":"e3437","DOI":"10.1002\/jgm.3437","article-title":"Intramyocardial adenoviral vascular endothelial growth factor-D\u2206N\u2206C gene therapy does not induce ventricular arrhythmias","volume":"24","author":"Leikas","year":"2022","journal-title":"J Gene Med"},{"issue":"24","key":"10.1053\/j.semtcvs.2024.11.009_bib25","doi-asserted-by":"crossref","first-page":"15514","DOI":"10.3390\/ijms232415514","article-title":"Modified mRNA therapeutics for heart diseases","volume":"23","author":"Magadum","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1053\/j.semtcvs.2024.11.009_bib26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0735-1097(03)00988-4","article-title":"A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina","volume":"42","author":"Grines","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semtcvs.2024.11.009_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ahj.2021.06.013","article-title":"Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (the EXACT trial): Rationale, design, and clinical considerations","volume":"241","author":"Povsic","year":"2021","journal-title":"Am Heart J"},{"issue":"1","key":"10.1053\/j.semtcvs.2024.11.009_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymthe.2003.09.014","article-title":"Adenovirus-mediated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs","volume":"9","author":"Whitlock","year":"2004","journal-title":"Mol Ther"},{"issue":"5","key":"10.1053\/j.semtcvs.2024.11.009_bib29","article-title":"Angiogenic gene therapy for refractory angina: results of the EXACT phase 2 trial","volume":"17","author":"Nakamura","year":"2024","journal-title":"Circ Cardiovasc Inter"},{"issue":"33","key":"10.1053\/j.semtcvs.2024.11.009_bib30","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/eurheartj\/ehx352","article-title":"Adenoviral intramyocardial VEGF-D\u0394N\u0394C gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I\/IIa study with 1-year follow-up","volume":"38","author":"Hartikainen","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1053\/j.semtcvs.2024.11.009_bib31","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ymthe.2022.11.017","article-title":"Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting","volume":"31","author":"Anttila","year":"2023","journal-title":"Mol Ther"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067924001138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067924001138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T18:42:22Z","timestamp":1744396942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067924001138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["S1043067924001138"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2024.11.009","relation":{},"ISSN":["1043-0679"],"issn-type":[{"type":"print","value":"1043-0679"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Directions in Coronary Revascularization for Refractory Angina: Gene Therapy and the Lizard Heart","name":"articletitle","label":"Article Title"},{"value":"Seminars in Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semtcvs.2024.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}